PREVALENCE AND MANAGEMENT OF OVARIAN TUMOURS IN WOMEN AND C HILDREN HOSPITAL ABBOTTABAD
AbstractBackground: I he purposes of study was to compare world incidence of ovarian tumours whether benign or malignantwith that of ‘our unit. We have also discussed management of all these patients at our center. Results: In our unit outof total 1400 admissions in 24 months. 26 had ovarian tumours, out of these 6 were malignant. The overall malignancyin our unit was 23% as compared to 15% of overall world incidence 24 of these patients, were admitted through theOPD with advanced size of tumours. None of them previously had any checkup at proper Gynecological Centers. AHthese 24 were admitted to the ward, investigated, operated and after receiving histopathology reports were furthermanaged accordingly. Two patients had torsion of ovarian tumour and were admitted through emergency and operatedas emergency cases in our study group the majority. 77% had benign ovarian tumours in which simplesalpingoophorectomies was performed.
Pell KR Benign and Malignant Tumour of the ovary.
Dewhurt’s textbook of Obstetrics and Gynaecology for
Postgraduate (5th Edition) Chapter 49, pp. 759-779.
Vicki V, Baker MD, Premalignant and malignant
disorders of the ovaries and oviducts. Current Obstetric
& Gynecologic Diagnosis and treatment (Eight Edition)
Prentice-Hall International. Inc., 1994, pp. 954-966.
Beral 1978. The Epidemiology of ovarian cancer, in
ovarian cancer – the way ahead. RCOG, London.
Gordon V, Navaynshi, Grant P, Cumming and David E.,
Parkin. The performance of screening test for ovarian
cancer of systemic review ((correspondence). Br. J Obs
and Gynecology, 1999, Vol 106; (10) 1107-1108.
Morgante G, Lamrca A, Delco L. Comparison of the
malignancy risk indces based serum CA125, ultrasound
score and menopausal status in the diagnosis of ovarian
amasses. Br J of Obs and Gynae Vol. 106 June 1999 pp,
Fathalla M.F. Incessant ovulation a factor in ovarian
neoplasia. Lancet 1971: ii, 163.
Kottmeir h (1982). Annual Report on the results of
treatment of gynecological cancer. No. 18, FICO,
Griffiths C.T. Surgical resection of tumour bulk in the
primary treatment of ovarian carcinoma. Nati Cancer inst
Monogr. 1975: 42, 101-104.
Jacos l.J, Stabile l, Bridges J, Multimodal approach to
screening for ovarian cancer. Lancet 1988: 1 268-271.
Jacobs I J., Stabile l, & Bast R.C. The CA125 tumourassociated antigen a review of the literature. Hum
Reprod 1989; 1:1-12.
Jacos l.J. & Oram D.H. (1990). Potential screening tests
for ovarian cancer. In Ovarian Cancer: Biological and
Therapeutic Challenges (F. Sharpe, W.P, Nason & R.E.
Leak, eds), Chapman and Hall, London, 197-205.
Herman U, Locher G, & Goldhiresch A. 1987.
Sonographic pattern of ovarian tumours: predication of
malignancy. Obstet Gynecol 69, 777-781.
Bourne. Screening for early familial ovarian cancer with
transvaginal ultrasonography and color flow imaging.
Br. Med J 1993: 306, 1025-1029.
Bourne. Ca ovarian masses be characterized using
ultrasound. Gynecol Oncol 1993; 51-4-6.
Kurjak A., Zalud l & Alfirecic Z., Evacuation of adnexal
masses with transvaginal colour ultrasound. J.
Ultrasounds Med 1991: 10, 295-297.
Suzuki M. Macrophage colony-stimulating factor as a
tuour marker for epithelial ovarian cancer. Obstet
Gynecol 1993; 946-50.
Saski H, Moda Ohmuru, Akiama M, Cliu et al. Ovarian
cyst detected by transvaginal sonography in the Tokyo
metropolitan area. Br. J of Gynea ad Obstetrics, May
Vol. 106 415-420.